Active · per the CBE, 16 November 2026

ESKA PHARMA

BE0840007528

Rechtspersoon Private limited company 1 establishment

ESKA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 6 October 2011, 1 establishment.

Antoine Dansaertstraat 1, 1000 Brussel

Active for

15 year, 1 month

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ESKA PHARMA from Brussel, company number BE0840007528, closed financial year 2025 with a result of € 105,760 after tax. For that financial year ESKA PHARMA recorded a gross margin of € 155,405 and equity of € 690,490. Compared with financial year 2024, the result moved from € 56,965 to € 105,760. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 690,490

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 105,760

▲ 86% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,642

▲ € 8,926 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 678,090.

People and assets in 2025

Wage cost

€ 30

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 11 years to go

€ 859,246

▼ 9% vs 2024

€ 81,648 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 2,096

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,455

▲ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 281,939 € 93,262 € 115,416 € 155,405 ▲ 35%
Profit after taxes € 213,170 € 18,170 € 56,965 € 105,760 ▲ 86%
Equity € 509,595 € 527,765 € 584,730 € 690,490 ▲ 18%
Total debts € 1,137,885 € 1,130,948 € 1,029,521 € 997,800 ▼ 3%
Cash € 3,858 € 11,124 € 716 € 9,642 ▲ € 8,926
Land & buildings € 689,394 € 674,242 € 659,091 € 643,939 ▼ 2%
Retained profit € 497,195 € 515,365 € 572,330 € 678,090 ▲ 18%
Dividend € 26,400 € 0 € 0 € 0
Bank debt € 1,096,740 € 1,018,792 € 939,636 € 859,246 ▼ 9%
Balance sheet total € 1,647,480 € 1,658,713 € 1,614,251 € 1,688,290 ▲ 5%

By gross margin, ESKA PHARMA ranks 285th of 1042 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Brussel that publish figures (fiscal year 2025).

Key figures of ESKA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ESKA PHARMA?

What happened at ESKA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 105,760 (▲ 86% vs 2024). filed late Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Brussel. KBO

In short

From € 213,170 profit in 2022 to € 105,760 profit in 2025.

Paid € 117,830 in corporate taxes since 2022.

Best year ever: 2022, with € 213,170 profit.

Paid out € 26,400 in dividends to the owners in total.

Establishments

Establishment units

Physical locations of this company

Registered office

Antoine Dansaertstraat 1

1000 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Brussel

Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 1395 active companies in Brussel, largest first.

Société Européenne de Gestion de l'Energie

€ 1.3 billion revenue · 2025

INTERNATIONAL TRADE

€ 933.7 million revenue · 2025

ACCENTURE

€ 469.5 million revenue · 2025

The Boston Consulting Group

€ 115.4 million revenue · 2025

PARTENA BUSINESS SOLUTIONS

€ 93.9 million revenue · 2025

OpticLibre Group

€ 53.4 million revenue · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • EL OUARDANI, Samia(oprichter) 100%

Details

Company number
0840.007.528
VAT number
BE 0840.007.528
Registered office
Antoine Dansaertstraat 1, 1000 Brussel
Names & denominations
ESKA PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
6 October 2011
Peppol
Active · Active since 4 Dec 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What does ESKA PHARMA do?
ESKA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 6 October 2011, 1 establishment.
What is the address of ESKA PHARMA?
The registered office of ESKA PHARMA is located at Antoine Dansaertstraat 1, 1000 Brussel.
Is ESKA PHARMA still active?
Yes. According to the CBE (16 November 2026) ESKA PHARMA is active, legal situation “Normale toestand”, started on 6 October 2011.
Is ESKA PHARMA registered on Peppol?
Yes, ESKA PHARMA is registered on the Peppol network with ID 0208:0840007528.
What is the enterprise number of ESKA PHARMA?
The enterprise number of ESKA PHARMA is BE0840007528.
When was ESKA PHARMA founded?
ESKA PHARMA was founded on 6 October 2011.